Form D · Pharmaceuticals

Biodel Inc

Danbury, CT · CIK 0001322505

Offering snapshot reported Jun 29, 2012 · SEC filing

Reported sold
$18.5M
Offering amount: $18.5M
Investors reported
19
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 27, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 29, 2012Initial$18,500,002No comparison19SEC filing
Mar 1, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Mar 28, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$1.11M
Finders' fees
$0
Form D file number
021-180500

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
William Blair & Company L.L.C.1252
JMP Securities LLC22208

Source: Form D, filed Jun 29, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Paul S. Bavier Executive
Julie R. Brown Director
Errol B. De Souza Director, Executive
Barry Ginsberg Director
Alan S. Krasner Executive
Ira W. Lieberman Director
Daniel Lorber Director
Gerard J. Michel Executive
Brian J.G. Pereira Director
Davey S. Scoon Director
Erik Steiner Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
100 Saw Mill Road
Danbury, CT, 06810